Form 8-K - Current report:
SEC Accession No. 0001104659-24-118906
Filing Date
2024-11-14
Accepted
2024-11-14 16:10:21
Documents
15
Period of Report
2024-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2428517d1_8k.htm   iXBRL 8-K 31198
2 EXHIBIT 99.1 tm2428517d1_ex99-1.htm EX-99.1 138088
6 GRAPHIC tm2428517d1_ex99-1img001.jpg GRAPHIC 13046
  Complete submission text file 0001104659-24-118906.txt   378059

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA elut-20241114.xsd EX-101.SCH 3006
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE elut-20241114_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elut-20241114_pre.xml EX-101.PRE 22353
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2428517d1_8k_htm.xml XML 3816
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
ELUTIA INC. (Filer) CIK: 0001708527 (see all company filings)

EIN.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39577 | Film No.: 241462198
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)